LEADER 05232nam 2200601 450 001 9910693573803321 005 20230902161935.0 010 $a1-280-10150-4 010 $a9786610101504 010 $a0-470-85927-X 010 $a0-470-86164-9 035 $a(CKB)111087027097492 035 $a(EBL)152674 035 $a(OCoLC)52546934 035 $a(MiAaPQ)EBC152674 035 $a(OCoLC)642828601 035 $a(EXLCZ)99111087027097492 100 $a20160815h20022002 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 00$aSchizophrenia /$fedited by Mario Maj, Norman Sartorius 205 $a2nd ed. 210 1$aChichester, West Sussex, England :$cWiley,$d2002. 210 4$dİ2002 215 $a1 online resource (516 p.) 225 1 $aWPA Series Evidence and Experience in Psychiatry ;$vVolume 2 300 $aDescription based upon print version of record. 311 $a0-470-84964-9 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aVOLUME 2 Schizophrenia Second Edition; Contents; List of Review Contributors; Preface; CHAPTER 1 DIAGNOSIS OF SCHIZOPHRENIA; Diagnosis of Schizophrenia: A Review; COMMENTARIES; 1.1 The Diagnosis of Schizophrenia: Practice and Concept; 1.2 Should Schizophrenia as a Disease Entity Concept Survive into the Third Millennium?; 1.3 On Defining Schizophrenia; 1.4 Diagnosis and Pathophysiology of Schizophrenia; 1.5 The Significance of Intuition for the Diagnosis of Schizophrenia; 1.6 Heterogeneity vs. Homogeneity in Operationally-diagnosed Schizophrenia 327 $a1.7 Diagnosis of Schizophrenia: Arguments for a Narrowing of the Concept 1.8 Schizophrenia: A Provisional Diagnostic Convention; 1.9 Diagnosing Schizophrenia: A Personal View; 1.10 Comments on the Diagnosis of the Schizophrenic Syndrome; 1.11 The Schizophrenic Syndrome: A Warning and a Conjecture; 1.12 A Century of Schizophrenia is Enough; 1.13 Diagnosis of Schizophrenia: A View from Developing Countries; 1.14 Studies on Schizophrenic Symptomatology in Peru; 1.15 Neuropsychological and Psychophysiological Contributions to the Diagnosis of Schizophrenia 327 $aCHAPTER 2 PHARMACOLOGICAL TREATMENT OF SCHIZOPHRENIA Pharmacological Treatment of Schizophrenia: A Review; COMMENTARIES; 2.1 Pharmacotherapy of Psychotic Disorders: A Perspective on Current Developments; 2.2 Pharmacotherapy of Schizophrenia: Gaps in our Knowledge; 2.3 Atypical Antipsychotic Drugs and Schizophrenia; 2.4 Compliance Issues and the New Antipsychotics; 2.5 Schizophrenia and Second-generation Antipsychotics: Mechanistic Implications and Potential for Early Intervention; 2.6 Dose and Duration of Antipsychotic Treatment: Key Variables, Critical Uncertainties 327 $a2.7 Dosing Problems of Classical Neuroleptics and the Relevance of Novel/Atypical Antipsychotics in the Pharmacotherapy of Schizophrenic Disorders 2.8 Can We Use Pharmacotherapy More Logically in Schizophrenia and Other Psychoses?; 2.9 Long-term Treatment in Schizophrenia: For Whom and How Long?; 2.10 Novel Antipsychotics in Schizophrenia and Related Disorders: Preliminary Findings from a First-episode Study; 2.11 The Pharmacotherapy of Schizophrenia in Clinical Practice; 2.12 A New Era of Hope in Treating Persons with Schizophrenia; 2.13 New Perspectives in Antipsychotic Pharmacotherapy 327 $a2.14 Some Aspects of the Maintenance Treatment of Schizophrenia 2.15 Highlights on the Management of Schizophrenia; 2.16 Pharmacotherapy of Schizophrenia: The Case of Developing Countries; CHAPTER 3 PSYCHOTHERAPIES FOR SCHIZOPHRENIA; Psychotherapies for Schizophrenia: A Review; COMMENTARIES; 3.1 Relevant Methods, Goals, Time-dimensions and Emotional Influences in the Psychotherapy of Schizophrenia; 3.2 Family and Individual Cognitive-Behavioural Interventions; 3.3 It is no Longer Surprising that Cognitive-Behavioural Therapy Reduces Distressing Psychotic Symptoms 327 $a3.4 Serious Questions Remain Concerning Efficacy, Effectiveness and Scope of Family Interventions in Schizophrenia 330 $aThis series acknowledges the substantial gap that still exists in psychiatry between research evidence and clinical practice: clinicians are sometimes incompletely aware of research findings, or regard them as biased, not convincing or not relevant to their practice. By using systematic reviews with accompanying commentaries this volume is able to assess the ""evidence"" and ""experiences"" to give a critical and objective account of the relevant issues, while focusing on key topics. This comprehensive book addresses schizophrenia through a systematic review of the available research evidence. 410 0$aWPA series, evidence and experience in psychiatry ;$vVolume 2. 606 $aSchizophrenia 615 0$aSchizophrenia. 676 $a616.8982 702 $aMaj$b Mario$f1953- 702 $aSartorius$b N. 712 02$aNational Institute of Mental Health (U.S.) 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910693573803321 996 $aSchizophrenia$91411695 997 $aUNINA